 |
Press Release
BurnsAdler
Partners to Expand Puerto Rico Franchise
Charlotte, North Carolina (February 9, 2005)
- BurnsAdler Pharmaceuticals, Inc. announced today that they
have partnered with QOL Medical, LLC for the promotion and
distribution of Sucraid® (sacrosidase) Oral Solution in Puerto
Rico. Sucraid® is the first and only pharmacologic therapy
approved by the FDA as a simple, safe and effective enzyme
replacement therapy of the genetically determined sucrase
deficiency, which is part of congenital sucrase-isomaltase
disease (CSID).
Bryan Somerville, Executive Vice President of BurnsAdler remarked,
"Sucraid® is an excellent niche gastroenterology product that
will dramatically increase the quality of life for children
with CSID. We continue to focus on expanding our franchise
in Puerto Rico, where products are often never launched or
are under utilized when compared to the U.S. Mainland. In
addition to Sucraid® we are planning on launching our viscosupplement,
NeoVisc®, immediately upon receipt of FDA approval."
Ron Morris, Vice President of QOL Medical added, "We are excited
to partner with BurnsAdler in Puerto Rico. We believe Sucraid®
will be successful in both filling an unmet medical need and
improving patient's lives in Puerto Rico." BurnsAdler is a
specialty pharmaceutical company that in-licenses and promotes
products in Europe, South America, Mexico, Canada, Puerto
Rico and the Caribbean. BurnsAdler's portfolio currently includes
products in the following fields: cardiovascular, orthopaedic,
oncology and epilepsy. QOL Medical LLC, headquartered in Mooresville,
North Carolina, is a specialty pharmaceutical development
and commercialization company dedicated to improving quality
of life for the patients they serve, their families and caregivers.
For additional information about this news release contact
Bryan Somerville at +1.704.552.8410 Ext. 223. For additional
information about BurnsAdler, please refer to the company's
website at www.burnsadler.com.
For additional information about QOL Medical LLC, please refer
to the company's website at www.qolmed.com.
|
BurnsAdler provides cost effective international product distribution and promotion for select emerging pharmaceutical companies.
 Print this page.
|
